Company News, People News

Revance Therapeutics Appoints Dr. Conor Gallagher Chief Scientific Officer

The promotion is part of Revance's ongoing commitment to innovation and scientific excellence, company officials said.

Biotech company Revance Therapeutics has promoted Conor Gallagher, PhD, to the role of chief scientific officer.    Dr. Gallagher joined Revance in April 2018 to lead the medical affairs group. Over the past few years, he expanded his role to oversee R&D, process and analytical development under the umbrella of scientific innovation. Additionally, he leads Revance's team working on the biosimilar program.    Prior to joining Revance, Dr. Gallagher spent 12 years at Alle...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters